9849658289?profile=original

Por Cristian Derosa

Diversas vacinas usadas no mundo são feitas com linhas de células fetais. NoSão tipos de células feitas em laboratório, mas baseadas em originais obtidas a partir de dois abortos feitos para este fim. Um deles foi em 1972 e o outro em 1985, ambos na Holanda.

Mas se você concorda que o consumidor final de produtos roubados ou ilicitamente adquiridos deva ser responsabilizado, entenderá que o uso desse material biológico é algo imoral.

Nos EUA, onde o debate bioético é algo mais comum, há empresas que desenvolvem as chamadas vacinas éticas ou morais, que não utilizam essas linhas celulares. Afinal, mesmo que tenham sido abortos feitos há muito tempo, nada garante que não estejam sendo feitos atualmente em países onde o aborto não é crime e a vida humana é, assim, relativizada.

As vacinas chinesas, como as da empresa Sinovac, informam não utilizar cultura de células fetais, mas de animais. No entanto, essa informação é altamente suspeita, uma vez que a China tem longa tradição de uso de células fetais para medicamentos e sendo o aborto lá livre de quaisquer amarras éticas.

Pensando em facilitar a vida de quem não pretende colaborar com o mal, a ONG pró-vida Children of God for Life listou as vacinas para Covid 19 que estão sendo desenvolvidas conforme os padrões éticos e morais aceitáveis e aquelas que não estão.

Veja, abaixo, a lista das vacinas éticas e não éticas:

VACINAS ÉTICAS (SEM CÉLULAS FETAIS)

AVM Biotech – AVM-0703
Treatment/Preventative
Steroid supercharge patient immune system
Steroid supercharges immune system, targeting Tcells, NKT (Natural Killer T) cells which attack and
kill Covid-19 virus.

www.avmbiotech.com

Israel – Pluristem
Using placenta donated from newborn babies


https://www.jpost.com/health-science/israeli-cell-therapy-totreat-acute-covid-19-patients-prevent-ards-621016

BCG Vaccine: No cells involved
https://www.fda.gov/media/78331/download
https://www.tribuneindia.com/news/nation/bcg-vaccine-to-betested-in-covid-19-battle-71090

British American Tobacco (BAT)
Tobacco company in Australia – morally
produced using tobacco leaves.
https://www.telegraph.co.uk/business/2020/04/01/cigarettemaker-claims-coronavirus-vaccine-breakthrough/

Novavax – NVX-CoV2373
https://ir.novavax.com/news-releases/news-releasedetails/novavax-identifies-coronavirus-vaccine-candidateaccelerates
Uses Insect cells:
https://www.novavax.com/page/8/vaccine-technologyMatrix uses Sapaonin:
https://www.novavax.com/page/10/matrix-madjuvant-technology

Athersys – Multistem – Treatment
Uses Bone Marrow Adult Stem Cells
https://seekingalpha.com/article/4332788-athersys-now-inplay-for-covidminus-19-fda-fast-tracked-therapy-for-ards

Sorrento Therapeutics
STI-6991 is an I-CellTM COVID-19 cellular vaccine
made of K562 cells expressing membrane-bound S1
protein of the SARS-CoV-2 virus
K562 cells – from 53 year old female cancer patient
https://finance.yahoo.com/news/sorrento-launchesnovel-cell-covid-140059499.html
And
https://www.sciencedirect.com/science/article/pii/S
2590098620300130?via%3Dihub

Sanofi Pasteur Sars-CoV – insect cells
https://www.hhs.gov/about/news/2020/02/18/hhsengages-sanofis-recombinant-technology-for-2019-
novel-coronavirus-vaccine.html
And
https://www.precisionvaccinations.com/sanofipasteur%C2%A0will-deploy-its-recombinant-dnaplatform-produce-recombinant-2019-novelcoronavirus

Sanofi Partners with GSK
Insect cells and AS03 adjuvant
https://www.wsj.com/articles/glaxosmithklinesanofi-team-up-for-coronavirus-vaccine11586875480?mod=lead_feature_below_a_pos1

Codagenix and Serum Institute
CDX-CoV – Uses Vero Cells
https://patents.google.com/patent/US20190233476
A1/en?assignee=codagenix&oq=codagenix
[0144] Materials and Methods

Symvivo
Uses e-Coli and Bifidobacterium
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnet
ahtml%2FPTO%2Fsearchbool.html&r=2&f=G&l=50&co1=AND&d=PTXT&s1=
symvivo&OS=symvivo&RS=symvivo

JPII Medical Research Inst. And CET
(Cellular Engineering Technology)
Uses stem cell from postnatal placental tissue
https://www.jp2mri.org/

Sinovac Biotech [SUSPEITA]
PiCoVacc – Uses Vero Cells
https://www.newsmedical.net/news/20200421/PiCoVacc-vaccinecandidate-for-COVID-19-effective-in-animal-trials.aspx

Regeneron – Sanofi
Treatment for Covid-19
Kevzara – Uses Blood donor and Chinese
Hamster Ovary (CHO cells)
Package insert:
http://products.sanofi.us/Kevzara/Kevzara.pdf
And Patent:
https://patents.google.com/patent/US8080248B2/en

Merck and IAVI
Using Merck’s Ervebo (Ebola Vaccine) Platform
Uses Vero cells
https://www.businesswire.com/news/home/2020052
6005274/en/

BioNTech and Pfizer
Uses K562 cells in protein expression
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2
Fnetahtml%2FPTO%2Fsearchbool.html&r=1&f=G&l=50&co1=AND&d=PTXT
&s1=bioNTech&OS=bioNTech&RS=bioNTech

Institute of Microbiology, Chinese Academy of Sciences, Zhifei Longcom
RBD-Dimer Uses Chinese Hamster Ovary cells
https://theprint.in/health/cansino-moderna-novavaxa-list-of-covid-vaccines-under-clinical-trials-acrossthe-world/454051/

Medicago/GSK/Dynavax
Uses VLPs produced in plant cells
https://www.ctvnews.ca/health/coronavirus/the-huntfor-a-vaccine-canadian-company-begins-humantesting-of-covid-19-candidate-1.5022960

VACINAS NÃO ÉTICAS (COM CÉLULAS FETAIS)

Moderna And NIAID
Vaccine candidate: mRNA-1273
Using HEK 293 and MRC-5 in
Development and Testing
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p
=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=
1&f=G&l=50&s1=10,583,203.PN.&OS=PN/10,583
,203&RS=PN/10,583,203
And
https://www.biocentury.com/article/304254/modern
a-novavax-among-biotechs-working-on-novelvirus-but-vaccine-at-least-a-year-out
And
https://science.sciencemag.org/content/367/6483/12
60.full

Johnson & Johnson/Janssen Tech.
Ad-Vac – uses aborted fetal PER C6
https://www.jnj.com/johnson-johnson-announces-alead-vaccine-candidate-for-covid-19-landmarknew-partnership-with-u-s-department-of-healthhuman-services-and-commitment-to-supply-onebillion-vaccines-worldwide-for-emergencypandemic-use
And
https://www.janssen.com/infectious-diseases-andvaccines/patented-technologies
And

Johnson & Johnson/Emergent Biosolutions
https://investors.emergentbiosolutions.com/newsreleases/news-release-details/emergentbiosolutions-signs-agreement-be-usmanufacturing?field_nir_news_date_value[min]=

Inovio Pharmaceuticals
Vaccine candidate: INO-4800
Uses HEK-293 cells
Based on current MERS-HCoV Platform
Patent no. 10,548,971 Feb 4, 2020
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p
=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=
1&f=G&l=50&s1=10,548,971.PN.&OS=PN/10,548
,971&RS=PN/10,548,971

The University of Oxford
Vaccine candidate: ChAdOx1 and AZD1222
Uses HEK-293 cells.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55
16308/
And
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33
96660/

And partnership with Merck Germany:
https://www.prnewswire.com/in/newsreleases/merck-supports-jenner-institute-to-reachfirst-milestone-in-covid-19-vaccine-manufacturing891225678.html

And partnership with AstraZeneca AZD1222
https://www.astrazeneca.com/content/astraz/mediacentre/press-releases/2020/astrazeneca-and-oxforduniversity-announce-landmark-agreement-forcovid-19-vaccine.html
And vaccine name change:
https://www.precisionvaccinations.com/vaccines/az
d1222-sars-cov-2-vaccine

CanSino Biologics
Vaccine candidate: Ad5-nCoV
http://www.cansinotech.com/homes/article/show/56
/153.html
Using HEK 293 cells (See page 25)
http://www.jshealth.com/jgzn/zzjg/ymlcpjs/ymlcpjs
_gzdt/201612/W020161214426550507006.pdf

University of Pittsburgh
Using HEK-293
https://pittsburgh.cbslocal.com/2020/04/02/universit
y-of-pittsburgh-medical-school-coronaviruspotential-vaccine-unveiled/
Linked in the article: Materials and Methods
https://www.thelancet.com/pdfs/journals/ebiom/PII
S2352-3964(20)30118-3.pdf

Altimmune
Based on intranasal vaccine proprietary
technology; Uses PER.C6
https://www.globenewswire.com/newsrelease/2020/02/28/1992600/0/en/AltimmuneCompletes-First-Development-Milestone-Towarda-Single-Dose-Intranasal-COVID-19-Vaccine.html
And Patent:
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2
Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=1
0,183,069.PN.&OS=PN/10,183,069&RS=PN/10,183,069

Massachusetts Eye and Ear
Using HEK-293 AAV Covid Adenovirus vector
http://patft.uspto.gov/netacgi/nphParser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2
Fnetahtml%2FPTO%2Fsearchbool.html&r=12&f=G&l=50&co1=AND&d=PTXT
&s1=Vandenberghe&OS=Vandenberghe&RS=Van
denberghe

Lindsley F. Kimball Research Institute, New York Blood Center and Beijing Institute of
Microbiology and Epidemiology
Uses HEK-293 cells
https://www.nature.com/articles/s41423-020-0400-
4#Sec1

Enviar-me um e-mail quando as pessoas deixarem os seus comentários –

DikaJob de

Para adicionar comentários, você deve ser membro de DikaJob.

Join DikaJob

Faça seu post no DikaJob